Publication:
Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia

dc.contributor.coauthorHo, S.
dc.contributor.coauthorWong, H. K.
dc.contributor.coauthorShqau, D.
dc.contributor.coauthorWinklmeier, S.
dc.contributor.coauthorGrobe-Einsler, M.
dc.contributor.coauthorRostasy, K.
dc.contributor.coauthorKümpfel, T.
dc.contributor.coauthorThaler, F. S.
dc.contributor.coauthorBrimberg, L.
dc.contributor.coauthorSchneider, M. A.
dc.contributor.coauthorMuley, T.
dc.contributor.coauthorSeifert-Held, T.
dc.contributor.coauthorEndmayr, V.
dc.contributor.coauthorHöftberger, R.
dc.contributor.coauthorFaber, J.
dc.contributor.coauthorKlopstock, T.
dc.contributor.coauthorFrahm, S.
dc.contributor.coauthorGerdes, L. A.
dc.contributor.coauthorMeinl, E.
dc.contributor.coauthorMader, S.
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentGraduate School of Health Sciences
dc.contributor.kuauthorVural, Atay
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.contributor.schoolcollegeinstituteGRADUATE SCHOOL OF HEALTH SCIENCES
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2026-07-17T08:30:13Z
dc.date.issued2026
dc.description.abstractCerebellar ataxias (CAs) encompass a wide spectrum of genetic and sporadic origins, of which a portion is driven by immune-mediated pathomechanisms. While some patients harbor known autoantibodies, assisting diagnosis and treatment, many remain seronegative. Here, we identify synaptophysin (SYP) as an autoantigen in CA by serum IgG staining on primate tissue, combined with human protein array and cell-based assay (CBA). SYP is abundant in presynaptic vesicles and is transiently exposed on the cell surface. Out of 43 patients with CA with synaptic serum reactivity on cerebellar sections, SYP antibodies were identified by CBA in 2 patients. Exposure of human induced pluripotent stem cell (iPSC)-derived glutamatergic neurons to patient’s IgG with SYP antibodies causes selective SYP accumulation at the presynaptic membrane. Patient’s IgG and SYP monoclonal antibody reduce neuronal populational activity recorded by multi-electrode array. Altogether, we identify SYP as an autoantigen for further stratifying patients with CA. Our functional experiments with SYP antibodies uncover a previously unrecognized mechanism of antibody-mediated synaptic dysfunction.
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis study has been enabled by the following: the Else Kroner-Fresenius-Stiftung (to S.M.), the Schering Stiftung and the Fritz Thyssen Foundation (to S.M.), the National Ataxia Foundation (to S.M.), the DFG (SFB TR128 and ME 1509/2-1 to E.M.), the Verein zurTherapieforschung fur MS Kranke (to E.M.), the Austrian Science Fund FWF SYNABS I6565-B (R.H.), Forschungsforderungsgesellschaft FFG IGNITEMIND FO999920011 (R.H.), and the Austrian Society of Neurology (Osterreichische Gesellschaft fur Neurologie) (R.H., T.S-H.). The authors would like to thank Betty Diamond, Sabine Liebscher, and Florence Bareyre for comments on the manuscript. The authors gratefully acknowledge access to clinically uncharacterized serum samples with granular layer staining pattern of unknown reactivity by the Mayo Clinic Neuroimmunology Laboratory. The authors gratefully acknowledge access to the longitudinal, multi-center cohort of consecutive patients with sporadic adult-onset ataxia (SPORTAX), as well as the samples and data provided by the Lung Biobank Heidelberg, part of the Biomaterial Bank Heidelberg (BMBH), and all participating centers that contributed samples to this study, as well as all patients involved. The authors would liketo thank Mike Cousin and Hisashi Umemori for providing the mCer-hSYP and rSYP-YFP plasmids, respectively. The authors are grateful to the Technology Platform Pluripotent Stem Cells of the Max Delbruck Center for providing the BIHi005-A-24 line and fortheir support with the MEA experiments. The authors are verygrateful to bit.bio for their generous support and expertise in the human iPSC-derived glutamatergic neurons. The authors would also like to extend their gratitude to PEPperPRINT for their continued support and to Ivanela Kondova for providing rhesus tissue blocks essential for establishment of assays, as well as Andree Schmidt for assistance during antigen identification. Furthermore, the authors would like to thank Andreas Thomae and Jan Brocher for valuable advice on image analyses and Tobias Straub and Yemil Atisha-Fregoso for statistical expertise. The authors are grateful to Stefan Lichtenthaler and Eric Chang for valuable discussions. Finally, the authors appreciate the technical support by Christian Lad, Yaren Canten, Ceren Ozdemir, Elif Donmez, and the clinical staffs at the outpatient clinic of the Institute of Clinical Neuroimmuniology of LMU Munich.
dc.description.versionPublished Version
dc.identifier.ScopusPercentile97
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile94.0
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.xcrm.2026.102822
dc.identifier.embargoN/A
dc.identifier.issn2666-3791
dc.identifier.issue6
dc.identifier.pubmed42155449
dc.identifier.scopus2-s2.0-105041689308
dc.identifier.urihttp://doi.org/10.1016/j.xcrm.2026.102822
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33505
dc.identifier.volume7
dc.identifier.wos001801568400002
dc.keywordsAutoantibodies
dc.keywordsSynaptophysin
dc.keywordsCerebellar ataxia
dc.keywordsNeuroinflammation
dc.keywordsAutoimmunity
dc.keywordsSynapse
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofCell Reports Medicine
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectCell biology
dc.titleSynaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublication2f870f28-12c9-4b28-9465-b91a69c1d48c
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication4c75e0a5-ca7f-4443-bd78-1b473d4f6743
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files